Search clinical trials for: FITBONE® Lengthening Nail

Total 69 results

Orthofix s.r.l.

Not yet recruiting

Study to Assess the Pain, Satisfaction, and Quality of Life of Patients With FITBONE® Lengthening Nail (FitForFrance)

Leg Length Inequality

France
Orthofix Inc.

Not yet recruiting

Post Market Evaluation of Clinical Safety and Performance of the Fitbone Transport and Lengthening System

Fractures, Bone | Fractures, Closed | Fractures, Open | Fracture of Femur | Fracture of Tibia | Limb Fracture | Fracture Nonunion | Limb Deformity | Limb Defect | Limb Asymmetry
Bilen, Fikri Erkal, M.D.

Completed

Simultaneous Lengthening of Bilateral Femora and Tibiae in Achondroplastic Patients

SHOX Gene With Short Stature

Turkey
Innovative Surgical Designs

Suspended

Pedicle Osteotomy for Stenosis Trial (POST)

Lumbar Spinal Stenosis | Spondylolisthesis, Grade 1 | Neurogenic Claudication

United States
Paragon 28

Completed

Multi-Plane Hallux Valgus Correction With the Phantom® Nail

Bunion | Hallux Valgus | Arthrodesis

United States
Aziyo Biologics, Inc.

Withdrawn

A Study Evaluating 3-Level OLIF Spine Fusion

Degenerative Disc Disease | Spondylolisthesis | Retrolisthesis
Stanford University

Not yet recruiting

Bio-Integrative, Fiber-Reinforced Kneebar for Treating Subchondral Insufficiency of the Knee

Subchondral Insufficiency Fracture

United States
LMU Klinikum

Unknown

Operative Treatment of 2-fragment-fractures (AO 11-A3) of the Proximal Humerus in the Elderly: Cement Augmented Locking Plate Philos vs. Proximal Humerus Nail MultiLoc

Shoulder Fractures | Intramedullary | Bone Plates

Germany
University Hospital, Strasbourg, France

Completed

Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study (PlasmaFaisa)

Septic Shock | Coagulopathy | Disseminated Intravascular Coagulation

France
University Hospital, Basel, Switzerland
Swiss National Science Foundation

Completed

PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION

Kidney Failure, Acute

Switzerland, Italy
Oslo University Hospital
University of Oslo; Norwegian University of Science and Technology; St. Olavs... and other collaborators

Completed

ASSessing the Effect of Anti-IL-6 Treatment in Myocardial Infarction: The ASSAIL-MI Trial (ASSAIL-MI)

Myocardial Infarction | Coronary Disease

Norway
Sandoz

Completed

A Local Clinical Study for the Comparative Evaluation of Efficacy and Safety of Angal, Lozenges [Menthol] and ANTI-ANGIN® FORMULA, Lozenges, in Treatment of Patients With a Sore Throat

Sore Throat

Russian Federation
King Abdullah International Medical Research Center

Unknown

M.I.P.O. vs Intramedullary Nailing in Tibia Fractures (MINT)

Tibia Fracture

Saudi Arabia
Samsung Medical Center

Completed

A Trial of Evonail® Solution for Prevention or Treatment of Onycholysis

Breast Cancer | Docetaxel Chemotherapy

Korea, Republic of
MiMedx Group, Inc.

Completed

Micronized dHACM Injectable for the Treatment of Plantar Fasciitis (dHACM)

Fasciitis, Plantar

United States
Kati Järvelä
Finnish Cultural Foundation

Completed

Effects of Hypertonic Saline-HES Solution on Extracellular Water in Cardiac Surgery Patients

Fluid Volume Disorder

Finland
Haukeland University Hospital

Withdrawn

"The Effect of Reduced Fluid Load After Cardiac Surgery"

Fluid Overload | Organ Edema | Organ Function
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America

Dengue | Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus

Puerto Rico, Colombia, Mexico, Honduras
Assistance Publique - Hôpitaux de Paris
Hoffmann-La Roche

Completed

Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Patients With Hand Osteoarthritis (TIDOA)

Hand Osteoarthritis

France
Sanofi Pasteur, a Sanofi Company

Completed

Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore

Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus | Dengue Diseases

Singapore
Cantonal Hosptal, Baselland
Clinical Trial Unit, University Hospital Basel, Switzerland

Withdrawn

Iron Substitution With Ferric Carboxymaltose as Treatment Strategy for Heart Failure Patients With Preserved Ejection Fraction (IRON-HFpEF)

Iron-deficiency | Heart Failure With Normal Ejection Fraction
Fresenius Kabi

Completed

Effects of Voluven on Hemodynamics and Tolerability of Enteral Nutrition in Patients With Severe Sepsis (CRYSTMAS)

Sepsis

France, Germany
Gilead Sciences

Completed

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy (POLARIS-2)

Hepatitis C

United States, France, United Kingdom, Germany, Canada, Australia, New Zealand, Puerto Rico
Medical University of Vienna
Medical University Innsbruck

Completed

Bortezomib in Late Antibody-mediated Kidney Transplant Rejection (BORTEJECT)

Antibody-mediated Rejection | Late Rejection of Renal Transplant

Austria
Vifor Pharma

Terminated

Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)

Thrombocytosis | Iron-Deficiency Anemia

Austria
Rennes University Hospital

Unknown

Effects of Intravenous Injection of Erythropoietin on Hepcidin Pharmacokinetics in Healthy Volunteers (HEPEPO)

Iron Metabolism Disorders

France
Cliniques universitaires Saint-Luc- Université...

Unknown

Which Apparatus for Inhaled Pentamidine?

Healthy

Belgium
Merck Sharp & Dohme LLC

Completed

Comparing 4.0 mg.Kg-1 Sugammadex With Placebo in the Reversal of Profound Neuromuscular Blockade (P05767)

Anesthesia | Neuromuscular Blockade
University of Arkansas

Recruiting

Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence

Squamous Cell Carcinoma of Head and Neck

United States
Albina Nowak, MD

Unknown

Effect of Iron on Cerebral Dopamine Receptor Density in Non-anaemic Premenopausal Women With Low Ferritin and Fatigue

Fatigue | Iron-deficiency

Switzerland
Reza Dana, MD
United States Department of Defense; New York Presbyterian Hospital; Bascom Palmer...

Completed

A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival

Corneal Neovascularization | Corneal Graft Failure

United States
Gilead Sciences

Completed

Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis (ASTRAL-4)

Hepatitis C Virus Infection

United States, Puerto Rico
Gilead Sciences

Completed

Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection

Hepatitis C Virus Infection

United States, Puerto Rico, New Zealand
Gilead Sciences

Completed

Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection

Hepatitis C Virus Infection

United States, Puerto Rico, New Zealand
Krankenhaus Barmherzige Schwestern Linz

Terminated

TOP-TRIAL Safety of Not Flushing Non-used PORT-A-CATH® in Cancer Patients

Solid Tumours | Adjuvant Chemotherapy | Port-A-Cath

Austria
Sanofi

Completed

A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines

Dengue Fever | Dengue Hemorrhagic Fever

Philippines
Vastra Gotaland Region

Recruiting

Optimal Coronary Flow After PCI for Myocardial Infarction - a Pilot Study (OPTIMAL)

ST-segment Elevation Myocardial Infarction

Sweden
Charite University, Berlin, Germany

Unknown

Glucagon Modulation of Ghrelin Secretion

Obesity | Diabetes Mellitus, Type 1 | Healthy Subjects

Germany
Sanofi Pasteur, a Sanofi Company

Completed

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects

Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus | Dengue Disease

Vietnam
Merck Sharp & Dohme LLC

Completed

Dose-Finding Trial With Sugammadex Administered at 3 and 15 Minutes After 1.0 and 1.2 mg/kg Rocuronium Bromide in Participants of ASA Class 1-3 (P05944; MK-8616-024)

Anesthesia, General
Norgine

Completed

A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution

Colonoscopy

Germany
Hospices Civils de Lyon

Terminated

Evaluation of the Effectiveness and Tolerance of Tetracosactide Synacthen® in the Treatment of Post Dural Puncture Headaches (ESYBRECHE) (ESYBRECHE)

Post-dural Puncture Headache

France
Prof. Dr. Berthold Schalke
Crolll Gmbh

Completed

Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size

Primary Inoperable Thymoma | Local Recurrent Thymoma

Germany
University Hospital, Strasbourg, France

Recruiting

Intravenous Immunoglobulins for the Treatment of Primary Sjögren's Syndrome Associated Painful Sensory Neuropathies (TINISS)

Primary Sjögren's Syndrome Painful Sensory Neuropathies

France
Ipsen

Completed

Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly (LANTERN)

Acromegaly

China
Reza Dana, MD

Completed

Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival

Corneal Neovascularization | Corneal Graft Failure

United States
Kristina Gemzell Danielsson

Completed

Paracervical Block During II-trimester Abortion

Second Trimester Medical Abortion

Sweden
University Hospital, Basel, Switzerland
Swiss National Science Foundation; Pharming Technologies B.V.

Recruiting

Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation (PAIR-TAVI)

Acute Renal Injury | Acute Ischemic Stroke

Switzerland
Assistance Publique - Hôpitaux de Paris

Recruiting

Certolizumab in Recurrent Implantation Failure (RIF) (CERTIFY)

Recurrent Unexplained Implantation Failure

France
Norgine

Completed

MOVIPREP® Versus NaP Pivotal Phase III Study

Colonoscopy

France

Search clinical trials for: FITBONE® Lengthening Nail

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations